Literature DB >> 24319335

Aqueous cytokines as predictors of macular edema in non-diabetic patients following uncomplicated phacoemulsification cataract surgery.

Liqun Chu1, Bingsong Wang, Bing Xu, Ning Dong.   

Abstract

PURPOSE: To ascertain whether cytokines in the aqueous humor can predict macular edema (ME) in non-diabetic patients following uncomplicated phacoemulsification cataract surgery.
METHODS: Undiluted aqueous humor samples were obtained from 288 consecutive non-diabetic patients (288 eyes; 132 men and 156 women) who underwent cataract surgery. Macular edema was defined as an increase in the foveal center point thickness (FCPT) more than 30% from the preoperative baseline using optical coherence tomography 4 weeks after cataract surgery. The concentrations of 27 cytokines were measured in aqueous humor samples using the multiplex bead immunoassay.
RESULTS: No major intraoperative complications occurred. The incidence of ME was 8.13% (23 patients) 4 weeks after cataract surgery. Compared to the ME (-) patients, the concentrations of interleukin-1β (IL-1β; p=0.016), IL-6 (p=0.013), monocyte chemotactic protein-1 (MCP-1; p=0.030), and vascular endothelial growth factor (VEGF; p=0.033) in the ME (+) patients were significantly higher. In addition, the aqueous humor levels of IL-1β (r=0.376), IL-6 (r=0.418), MCP-1 (r=0.348), and VEGF (r=0.375) positively correlated with the postoperative FCPT. However, the aqueous humor levels of IL-10 (p=0.017) were significantly lower in patients with ME and were negatively correlated with the postoperative FCPT (r=-0.424).
CONCLUSIONS: IL-1β, IL-6, MCP-1, VEGF, and IL-10 may be potential predictors of postoperative macular thickness in non-diabetic patients following uncomplicated phacoemulsification cataract surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24319335      PMCID: PMC3850971     

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


Introduction

Cataracts are the most common eye disease that may lead to blindness and severe visual impairment among adults aged 50 years or older in China. More than 5 million cataract operations are performed annually in China, suggesting that cataract extraction is the most frequently performed ophthalmic surgery. At present, the incidence of postoperative complications is decreasing with the development of phacoemulsification and posterior chamber intraocular lens implantation. However, anterior segment inflammation and macular edema (ME) are the most common complications of uneventful cataract surgery [1]. ME is one of the main causes of unfavorable visual outcomes following uncomplicated cataract surgery and can result in permanent visual loss [2]. The reported incidence of ME ranges from 4% [3] to 11% [4] following uncomplicated phacoemulsification cataract surgery. ME can be observed angiographically (seen using fluorescein angiography in patients who do not suffer from a detectable visual impairment) or clinically (associated with decreased visual acuity) [5]. Although the pathogenesis of ME is likely multifactorial and remains unknown, it appears to be associated with postoperative inflammation induced by prostaglandins or other inflammatory mediators [3,6]. Inflammatory mediators break down the blood–retinal barrier and the blood–aqueous barrier, leading to increased vascular permeability [7]. A previous study measured the concentrations of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) in aqueous humor in patients with nonproliferative diabetic retinopathy with enzyme linked immunosorbent assay during cataract surgery [8] and demonstrated that high VEGF levels in the aqueous humor predict a significant risk of postoperative exacerbation of ME [8]. However, the limitations of the previous study on aqueous humor cytokines include the examination of a limited number of cytokines. Exploring a greater number of cytokines would provide broader insight into the inflammatory mechanisms involved. Recently, the multiplex bead immunoassay has been used to detect cytokines in tears and the aqueous humor because of the capacity of this assay to simultaneously quantify multiple cytokines in small sample volumes [9-12]. Therefore, in this study, we used the multiplex bead immunoassay to evaluate the concentrations of 27 cytokines in the aqueous humor at the beginning of cataract surgery and correlate their expression levels to the development of ME 4 weeks after surgery. In addition, our study explores whether cytokine concentrations in the aqueous humor can predict ME after phacoemulsification.

Methods

The present study used a comparative cross-sectional design and recruited participants between January 2012 and January 2013. The survey included 288 consecutive non-diabetic patients (288 eyes; 132 males and 156 females) who underwent cataract surgery from Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China. The mean age of the patients was 71.6 years (range, 58–88 years). The study was approved by the Ethics Committee of Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China, and the study was performed in accordance with the Declaration of Helsinki. Each participant received detailed information and provided informed written consent before being included in the study. Subjects with blood pressure above 140/90 mmHg or who were receiving any antihypertensive medications were considered hypertensive. Hypercholesterolemia was defined as a fasting total plasma cholesterol level above 200 mg/dl. Hypertriglyceridemia was classically defined as a fasting plasma triacylglycerol (triglycerides, TG) level above 200 mg/dl. Inclusion criteria for all patients were the absence of any retinal or optic nerve disease. Exclusion criteria included the following: (1) a history of ocular surgery; (2) subcapsular posterior cataract; (3) diabetes; (4) age-related macular disease; (5) and intraoperative complications such as posterior capsule rupture, vitreous loss, or lens fragments in the vitreous. Patients underwent preoperative ophthalmologic examination and a physical examination that included best-corrected visual acuity (BCVA), electroretinogram (ERG), slit lamp-assisted biomicroscopy of the anterior segment, fundus examination, and optical coherence tomography (OCT), which was used to measure the foveal center point thickness (FCPT). The BCVA was measured with a Snellen chart at the preoperative examination 1 day and 4 weeks postoperatively. The OCT examination (Stratus OCT3; Carl Zeiss Meditec, Dublin, CA) was performed by an experienced operator through a dilated pupil. Each study eye underwent OCT testing fewer than 2 weeks before cataract surgery. OCT images were generated with the use of six radial-line scans, 6.00 mm each in length. The maximal foveal center point thickness (in micrometers) was measured at the center point of the fovea by manually placing computerized calipers at the vitreous–retina and retina–retinal pigment epithelium interfaces [13].

Surgical technique

All cataract surgeries were performed using the phacoemulsification technique and the insertion of a foldable hydrophilic acrylic intraocular lens (Acrysof IQ IOL, Alcon, Fort Worth, TX) in the capsular bag. A total of 0.3 mg TobraDex ointment (tobramycin 0.3% and dexamethasone 0.1%; Alcon) was used at the end of the surgery in all patients. All patients were instructed to administer TobraDex eye drops (tobramycin 0.3% and dexamethasone 0.1%; Alcon) four times daily for 2 weeks after surgery and two times daily until 4 weeks post-cataract surgery. In addition, all patients were instructed to administer 0.1% diclofenac sodium eye drops four times daily for 4 weeks after surgery. All patients were followed for at least 4 weeks after surgery.

Aqueous humor sampling

At the time of cataract surgery, a limbal paracentesis was made with a sterile tuberculin syringe. Undiluted aqueous humor samples (0.1–0.2 ml) were aspirated into a syringe. The samples were immediately frozen and stored at −80 °C until analysis.

Postoperative evaluation

Postoperative follow-up visits were scheduled for 1 day and 4 weeks post-cataract surgery. The following assessments were performed 1 day post-cataract surgery: BCVA, slit lamp-assisted biomicroscopy, fundus examination, and intraocular pressure. The following assessments were performed 4 weeks post-cataract surgery: BCVA, slit lamp-assisted biomicroscopy, intraocular pressure, fundus examination, and OCT.

Definition of postoperative macular edema

ME was defined as an increase in the center point thickness of more than 30% from the preoperative baseline on OCT 4 weeks after cataract surgery [2,13]. All patients were divided into either the ME group [ME (+)] or the non-ME group [ME (-)].

Multiplex analysis of cytokines in the aqueous humor

The Bio-Plex Pro magnetic color bead-based multiplex assay (Bio-Plex Human Cytokine 27-plex panel; Bio-Rad, Hercules, CA) was used to measure the concentrations of 27 human aqueous humor cytokines: interleukin-1β (IL-1β), IL-1rα, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL-17, basic fibroblast growth factor (b-FGF), eotaxin, granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GMCSF), interferon-gamma (IFN-γ), interferon-induced protein-10 (IP-10 or CXCL10), monocyte chemotactic protein-1 (MCP-1 or CCL2), macrophage inflammatory protein-1α (MIP-1α or CCL3), macrophage inflammatory protein-1β (MIP-1β or CCL4), platelet-derived growth factor-BB (PDGF-BB), regulated upon activation normal T-cell expressed and secreted (RANTES), tumor necrosis factor-alpha (TNF-α), and VEGF. The analysis procedure was conducted according to the manufacturer’s instructions. Standard curves were generated by using the reference cytokine sample supplied in the kit and the Bio-Plex 200 System (software version 6.0; Bio-Rad Laboratories) and were used to calculate the cytokine concentrations in aqueous humor samples.

Statistical analysis

Data were recorded as the mean±standard deviation (SD) or as the median and range. The BCVA values were converted to the logarithm of the minimum angle of resolution (logMAR). The statistical analyses were performed using SPSS for Windows Version 17.0 (Chicago, IL). The Pearson χ2 test was used to compare the proportion of the qualitative variables. The Student t test and the Mann–Whitney U test were used to compare the means of the quantitative variables between two independent groups. Pearson correlation coefficients were used to assess the relationship between the concentrations of the assayed cytokines and the foveal center point thickness 4 weeks post-cataract surgery. A p value less than 0.05 was accepted as statistically significant.

Results

Patient demographics

A total of 288 consecutive non-diabetic patients (288 eyes) were enrolled, and there were no cases of intraoperative vitreous loss or suprachoroidal hemorrhage. At the final follow-up examination, 283 patients (283 eyes) completed 4 weeks of follow-up (98.3% completion), and the five patients who did not complete the protocol were excluded from the study. In the entire study population, 23 patients (23 eyes; 9 men and 14 women) had an increase in the center point thickness of more than 30% from the preoperative baseline on OCT 4 weeks after cataract surgery. The incidence of ME was 8.13%. Table 1 shows the demographic and clinical characteristics of the patients, including the 23 consecutive ME (+) patients and 23 ME (-) patients (23 eyes; 11 men and 12 women) who were randomly selected from the ME (-) group by a random number table. There were no significant differences in age, hypertension, blood glucose level, cholesterol, triglycerides, type of cataract, and iris color between the ME (+) and ME (-) groups.
Table 1

Baseline characteristics of patients with ME (-) AND ME (+).

CharacteristicsME (-)ME (+)P value
Number
23
23
-
Gender


0.552a
Male (%)
11 (47.8)
9 (39.1)

Female (%)
12 (52.2)
14 (60.9)

Age (SD)
70.8 (8.47)
73.6 (7.43)
0.215b
Hypertension (%)
14 (60.9)
13 (56.5)
0.765a
Hypercholesterolemia (%)
7 (30.4)
9(39.1)
0.536a
Hypertriglyceridemia (%)
5 (21.7)
8 (34.8)
0.326a
Blood glucose level, mmol/l (SD)
4.98 (0.73)
5.27 (0.67)
0.139b
Type of cataract


0.552a
Cortical (%)
9 (39.1)
11 (47.8)

Nuclear (%)
14 (60.9)
12 (52.2)

Iris color


0.300a
Dark (%)
16 (69.6)
19 (82.6)

Light (%)7 (30.4)4 (17.4)

aPearson χ2 test; bStudent t test.

aPearson χ2 test; bStudent t test.

Postoperative clinical characteristics

The mean BCVA before surgery was 0.50±0.22 (logMAR) in the ME (-) group and 0.47±0.21 (logMAR) in the ME (+) group. Table 2 shows the BCVA 1 day and 4 weeks after surgery. The postoperative BCVA was not significantly different between the ME (-) and ME (+) groups.
Table 2

Preopertive, 1-day and 4-week post–cataract surgery bcva for eyes with ME (-) and ME (+).

TimelogMAR BCVA

ME (-), n=23ME (+), n=23P valuea
Preoperative
0.50±0.22
0.47±0.21
0.687
1-day
0.09±0.15
0.07±0.15
0.618
4-week0.04±0.160.12±0.110.067

logMAR=logarithm of the minimum angle of resolution; BCVA=best-corrected visual acuity. aStudent t test.

logMAR=logarithm of the minimum angle of resolution; BCVA=best-corrected visual acuity. aStudent t test. The mean foveal center point thickness before surgery was 161.03±22.56 µm in the ME (-) group and 163.39±18.72 in the ME (+) group. Table 3 shows the FCPT 4 weeks after surgery. At 4 weeks, there was an increase of 17.39 µm and 62.7 µm in the FCPT of the ME (-) and ME (+) groups, respectively. The postoperative FCPT differed significantly between the ME (-) and ME (+) groups.
Table 3

Preopertive and 4-week post–cataract surgery foveal center point thickness for eyes with ME (-) and ME (+).

TimeFoveal center point thickness (µm)

ME (-), n=23ME (+), n=23P valuea
Preoperative
161.03±22.56
163.39±18.72
0.773
4-week178.42±22.01226.09±26.26<0.001

aStudent t test.

aStudent t test. Table 2 and Table 3 show the average increase in center point thickness at 4 weeks for eyes with ME was 62.7 µm, which resulted in a nearly 1-line loss of vision (0.05 logMAR units) compared to eyes without ME, which gained approximately 1 line of vision (0.05 logMAR units). However, the patients with ME did not suffer from a serious visual impairment during the 4 weeks after cataract surgery.

Cytokine concentrations in the aqueous humor

Table 4 shows the concentrations of the assayed cytokines. Positive detection rates were more than 80% for 21 cytokines. The positive detection rates for the other six cytokines were IL-13 (66%), TNF-α (50%), IL-17 (36%), G-CSF (28%), IFN-γ (26%), and MIP-1α (18%); these cytokines were not included in the statistical analysis because of the low detection rates.
Table 4

The concentrations of cytokines in aqueous humors of eyes with ME (-) and ME (+).

CytokineME (-), n=23
ME (+), n=23
P valuea
MedianRangeMedianRange
IL-1β
2.0
0–38
5.0
0–34
0.016
IL-1rα
15.1
0–323
17.2
0–356
0.560
IL-2
1.7
0–118
1.9
0–136
0.768
IL-4
1.4
0–133
1.7
0–124
0.850
IL-5
1.3
0–151
2.1
0–121
0.752
IL-6
13.0
0–26
17.0
0–42
0.013
IL-7
4.7
0–95
2.2
0–86
0.130
IL-8
6.6
0–86
8.0
0–106
0.112
IL-9
2.9
0–87
2.6
0–102
0.620
IL-10
7.0
0–33
5.0
0–13
0.017
IL-12
8.3
0–86
9.6
0–102
0.531
IL-13
-
-
-
-
-
IL-15
1.3
0–58
1.7
0–96
0.733
IL-17
-
-
-
-
-
b-FGF
13.2
0–165
11.1
0–178
0.780
Eotaxin
5.7
0–103
6.1
0–116
0.813
G-CSF
-
-
-
-
-
GM-CSF
6.7
0–88
7.5
0–79
0.673
IFN-γ
-
-
-
-
-
IP-10
1.1
0–26
0.9
0–19
0.732
MCP-1
79.5
23–276
134.0
24–269
0.030
MIP-1α
-
-
-
-
-
MIP-1β
32.8
0–213
33.5
0–232
0.630
PDGF-BB
3.1
0–66
3.8
0–71
1.000
RANTES
5.3
0–83
5.9
0–93
0.661
TNF-α
-
-
-
-
-
VEGF38.011–29876.013–2460.033

aMann–Whitney U test

aMann–Whitney U test Compared to the ME (-) group, the concentrations of IL-1β (p=0.016), IL-6 (p=0.013), MCP-1 (p=0.030), and VEGF (p=0.033) in the ME (+) patients were significantly higher. However, the IL-10 concentrations in the samples from the ME (+) patients (p=0.017) were significantly lower. There were no significant differences in the other cytokine concentrations between the ME (-) and ME (+) patients.

Association between cytokine concentrations and foveal center point thickness

Table 5 shows the relationship between the concentrations of the assayed cytokines and the postoperative FCPT. The aqueous humor levels of IL-1β (r=0.376), IL-6 (r=0.418), MCP-1 (r=0.348), and VEGF (r=0.375) correlated positively with postoperative FCPT. In addition, the aqueous humor level of IL-10 (r=–0.424) was negatively correlated with the postoperative FCPT.
Table 5

Correlations between concentrations of cytokines in aqueous humors and 4-week post–cataract surgery foveal center point thickness.

CytokineCorrelation coefficientsP valuea
IL-1β
0.376
0.003
IL-6
0.418
0.001
IL-10
−0.424
0.001
MCP-1
0.348
0.007
VEGF0.3750.003

aPearson correlation coefficient

aPearson correlation coefficient

Discussion

The incidence of ME peaks at approximately 4 to 6 weeks after uneventful cataract surgery [4,14]. The incidence of angiographic ME has been reported to range from 4% [3] to 11% [4] following uncomplicated phacoemulsification cataract surgery; however, the prevalence of clinical ME is much lower and ranges from 0.1% to 2.35% [15-17]. The different rates may be caused by several factors, such as the type of cataract, surgical technique, time of phacoemulsification, variation in follow-up times, and rates of complications [6]. In the current study, 23 patients (23 eyes; nine men and 14 women) had an increase in the center point thickness of more than 30% from the preoperative baseline on OCT 4 weeks after cataract surgery, and the incidence of ME was 8.13% [2,13]. The average increase in center point thickness at 4 weeks for eyes with ME was 62.7 µm, which resulted in a nearly 1-line loss of vision (0.05 logMAR units) compared to eyes without ME, which gained approximately 1 line of vision (0.05 logMAR units). However, the patients with ME did not suffer from a serious visual impairment during the 4 weeks after cataract surgery. There may be several explanations for these results. First, no clinical ME was associated with decreased visual acuity because our cataract surgeries were routine and uncomplicated phacoemulsification cataract surgeries. In addition, all surgeries were performed by the same experienced expert. Second, our follow-up observation period was only 4 weeks, and the incidence of significant clinical ME may increase after 4 weeks. Therefore, our study on the incidence of ME after uneventful cataract surgery must continue. The pathophysiology of ME involves the accumulation of transudate in the outer plexiform and the inner nuclear layers of the retina; the microcysts coalesce into cysts [5]. The pathogenesis of ME is associated with the destruction of the blood–retinal barrier and the blood–aqueous barrier induced by prostaglandins or other inflammatory mediators [3,6,7]. Elevated levels of angiogenic factors, inflammatory cytokines, chemokines, and growth factors in the aqueous humor may play a role in the breakdown of the vascular barrier [18-22]. Aqueous humor analysis provides useful tools in understanding the pathophysiology and treatment response to many ocular conditions. However, aqueous humor samples consist of small volumes, limiting the usefulness of the analysis with traditional enzyme linked immunosorbent assay techniques. In the current study, multiplex bead immunoassay was used to analyze the aqueous humor levels of cytokines and chemokines in non-diabetic patients following uncomplicated phacoemulsification cataract surgery. Multiplex assays measure the concentrations of multiple cytokines simultaneously in small sample volumes, such as those of the aqueous humor, serum, and tears [23,24]. Using multiplex assays, we simultaneously measured the concentrations of 27 cytokines in human aqueous humor samples. To our knowledge, this sample is comparatively large, and this is the first investigation of these 27 aqueous cytokines as predictors of ME in non-diabetic patients following uncomplicated phacoemulsification cataract surgery. In our study, positive detection rates were more than 80% for 21 cytokines. Compared to the ME (-) patients, the concentrations of IL-1β (p=0.016), IL-6 (p=0.013), MCP-1 (p=0.030), and VEGF (p=0.033) were significantly higher in the ME (+) patients. In addition, the aqueous humor levels of IL-1β (r=0.376), IL-6 (r=0.418), MCP-1 (r=0.348), and VEGF (r=0.375) correlated positively with postoperative FCPT. IL-1β is a proinflammatory cytokine and angiogenic mediator [25]. IL-1β upregulates several inflammatory mediators, including IL-1β itself, TNF-α, cyclooxygenase 2 (COX-2), prostaglandins, inducible nitric oxide synthase (iNOS), and chemokines [26]. Meanwhile, experimental studies have demonstrated the in vivo angiogenic activity of IL-1β, and its influence on the development of ocular neovascularization [27,28]. In the current study, the IL-1β concentrations in the ME (+) patients were significantly higher than those of the ME (-) group. Our study suggests a possible role of IL-1β in the development of ME after cataract surgery, and we will need to prove if using IL-1β receptor antagonists or otherwise neutralizing IL-1β can inhibit the development of ME. IL-6 is synthesized by various cells, including epidermal cells, fibroblasts, macrophages, vascular smooth muscle, vascular endothelial cells, and glial cells [29,30]. Furthermore, IL-6 is a multifunctional, proinflammatory cytokine that increases vascular permeability and angiogenesis through inducing VEGF [29,30]. MCP-1 (CCL2) is a member of the C-C chemokine family, which regulates the migration and infiltration of monocytes/macrophages [31]. This protein was a well-known proinflammatory cytokine, and aqueous MCP-1 levels were elevated in human and animal eyes after phacoemulsification [32]. In our study, the IL-6 and MCP-1 concentrations from the ME (+) patients were significantly higher than those of the ME (-) patients. There is evidence that inflammation is an important molecular mechanism in the development and progression of ME after uncomplicated phacoemulsification cataract surgery. VEGF is an endothelial cell mitogen that induces an increase in vascular permeability and angiogenesis, which potently activate angiogenesis, enhance collateral vessel formation, and increase the permeability of the microvasculature [33]. In accordance with previous results, levels of VEGF in the aqueous humor have markedly increased in postoperative exacerbation of patients with ME [8]; therefore, aqueous cytokines may be a predictor of ME in non-diabetic patients after cataract surgery. IL-10, which is produced by monocytes and macrophages, is a primary anti-inflammatory cytokine. IL-10 limits inflammation by reducing the synthesis of proinflammatory cytokines, such as IL-1 and TNF-α, by suppressing cytokine receptor expression and inhibiting receptor activation [34]. In addition, IL-10 prevents angiogenesis by downregulating VEGF expression [35]. In our study, the IL-10 concentrations of samples from the ME (+) patients (p=0.017) were significantly lower. Our results suggest that low levels of circulating IL-10 (anti-inflammatory and antiangiogenic activity) are involved in the pathogenesis of ME after cataract surgery. The limitations of our study should be mentioned. First, our study was limited to non-diabetic patients with uncomplicated phacoemulsification cataract surgery and a relatively short follow-up observation period in which the prevalence of ME was comparatively low and the prevalence of clinical ME was none after cataract surgery. In addition, the concentration of the cytokines was not determined from vitreal samples. The cytokine levels in the vitreous humor usually show higher concentrations, and analysis of the vitreal samples would more accurately reflect the intraocular cytokine concentrations and the condition of the macula. However, in contrast to vitreous samples, obtaining aqueous fluid samples from the anterior chamber is easier, faster, and less risky. Finally, multiplex bead immunoassay has a limitation if the cytokine levels are low. Thus, the positive detection rates for the six cytokines were not higher than 80%, and these cytokines were not included in the statistical analysis because of the low detection rates in the current study. In conclusion, the present study showed that the aqueous humor levels of IL-1β, IL-6, MCP-1, and VEGF were increased in patients with post-cataract surgery ME and were positively correlated with FCPT 4 weeks following cataract surgery in non-diabetic patients. In addition, the aqueous humor levels of IL-10 were significantly lower in patients with post-cataract surgery ME and were negatively correlated with postoperative FCPT. These results indicate that the aqueous humor levels of IL-1β, IL-6, MCP-1, VEGF, and IL-10 may be potential predictors of postoperative exacerbation of ME in non-diabetic patients following uncomplicated phacoemulsification cataract surgery.
  34 in total

Review 1.  Interleukin 1 in the brain: biology, pathology and therapeutic target.

Authors:  N J Rothwell; G N Luheshi
Journal:  Trends Neurosci       Date:  2000-12       Impact factor: 13.837

Review 2.  Cystoid macular edema following cataract surgery.

Authors:  L Rossetti; A Autelitano
Journal:  Curr Opin Ophthalmol       Date:  2000-02       Impact factor: 3.761

3.  Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity.

Authors:  Gokhan Gulkilik; Selim Kocabora; Muhittin Taskapili; Gunay Engin
Journal:  Can J Ophthalmol       Date:  2006-12       Impact factor: 1.882

Review 4.  Interleukin-6: a comprehensive review.

Authors:  M Lotz
Journal:  Cancer Treat Res       Date:  1995

5.  Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.

Authors:  N Demircan; B G Safran; M Soylu; A A Ozcan; S Sizmaz
Journal:  Eye (Lond)       Date:  2005-11-11       Impact factor: 3.775

6.  Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb.

Authors:  J S Silvestre; Z Mallat; M Duriez; R Tamarat; M F Bureau; D Scherman; N Duverger; D Branellec; A Tedgui; B I Levy
Journal:  Circ Res       Date:  2000-09-15       Impact factor: 17.367

7.  Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy.

Authors:  Carin Gustavsson; Carl-David Agardh; Elisabet Agardh
Journal:  Acta Ophthalmol       Date:  2012-04-20       Impact factor: 3.761

8.  Prediction of macular edema exacerbation after phacoemulsification in patients with nonproliferative diabetic retinopathy.

Authors:  Hideharu Funatsu; Hidetoshi Yamashita; Hidetaka Noma; Erika Shimizu; Tatsuya Mimura; Sadao Hori
Journal:  J Cataract Refract Surg       Date:  2002-08       Impact factor: 3.351

9.  Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.

Authors:  Hideharu Funatsu; Hidetoshi Yamashita; Tomohiro Ikeda; Tatsuya Mimura; Shuichiro Eguchi; Sadao Hori
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  15 in total

1.  Long-term results of cataract surgery in patients with anterior uveitis.

Authors:  Ozgur Balta; Gulten Sungur; Mehmet Akif Acar; Mustafa Kosker; Mehmet Yakin; Firdevs Ornek
Journal:  Int Ophthalmol       Date:  2017-06-10       Impact factor: 2.031

2.  Effect of preoperative eyedrops on cytokine concentrations in aqueous humor of patients undergoing femtosecond laser-assisted cataract surgery.

Authors:  Jae Hyuck Lee; Ho Seok Chung; Su Young Moon; Jooyoung Yoon; Koeun Lee; Hun Lee; Jae Yong Kim; Hyun Taek Lim; Hungwon Tchah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-09       Impact factor: 3.117

3.  Anti-interleukin-6 receptor therapy with tocilizumab for refractory pseudophakic cystoid macular edema.

Authors:  Brandon Huy Pham; Doan Luong Hien; Wataru Matsumiya; Than Trong Tuong Ngoc; Huy Luong Doan; Amir Akhavanrezayat; Çigdem Yaşar; Huy Vu Nguyen; Muhammad Sohail Halim; Quan Dong Nguyen
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-20

4.  Study of 27 Aqueous Humor Cytokines in Type 2 Diabetic Patients with or without Macular Edema.

Authors:  Ning Dong; Bing Xu; Liqun Chu; Xin Tang
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

5.  Aqueous cytokines as predictors of macular edema in patients with diabetes following uncomplicated phacoemulsification cataract surgery.

Authors:  Ning Dong; Bing Xu; Bingsong Wang; Liqun Chu; Xin Tang
Journal:  Biomed Res Int       Date:  2015-02-25       Impact factor: 3.411

6.  Analysis of aqueous humor concentrations of cytokines in retinoblastoma.

Authors:  Yong Cheng; Shufeng Zheng; Chung-Ting Pan; Mengke Yuan; Libin Chang; Yuou Yao; Mingwei Zhao; Jianhong Liang
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

7.  Development of diabetic retinopathy after cataract surgery.

Authors:  Chi-Juei Jeng; Yi-Ting Hsieh; Chung-May Yang; Chang-Hao Yang; Cheng-Li Lin; I-Jong Wang
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

Review 8.  Measuring Anterior Chamber Inflammation After Cataract Surgery: A Review of the Literature Focusing on the Correlation with Cystoid Macular Edema.

Authors:  Michele De Maria; Danilo Iannetta; Luca Cimino; Marco Coassin; Luigi Fontana
Journal:  Clin Ophthalmol       Date:  2020-01-09

9.  Fellow-Eye Comparison between Phaco-Microhook Ab-Interno Trabeculotomy and Phaco-iStent Trabecular Micro-Bypass Stent.

Authors:  Yuji Takayanagi; Sho Ichioka; Akiko Ishida; Aika Tsutsui; Masaki Tanito
Journal:  J Clin Med       Date:  2021-05-14       Impact factor: 4.241

10.  Role of Cold Balanced Salt Solution (BSS) in the Prophylaxis of Cystoid Macular Edema After Cataract Surgery: A Prospective Randomized Study.

Authors:  Alessandro Meduri; Giovanni William Oliverio; Loredana Bergandi; Gabriella De Salvo; Rino Frisina; Cosimo Mazzotta; Pasquale Aragona
Journal:  Clin Ophthalmol       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.